MMJ PhytoTech Limited (ASX:MMJ) ("MMJ" or "the Company") is pleased to advise that TSX-V listed Harvest One Cannabis Inc. (CVE:HVST) ("Harvest One"), of which MMJ holds 53,333,333 shares, has released an operational update on its wholly-owned horticultural subsidiary United Greeneries Ltd ("United Greeneries").

The update provides details on United Greeneries' expansion targets of 20,000kg dried cannabis flower capacity by YE 2018 and 70,000kg dried flower capacity by YE 2019 - which is anticipated to be fully-funded by Harvest One's existing cash position of approximately C$80 million.

About Harvest One Cannabis Inc.

Harvest One Cannabis Inc. (CVE:HVST) controls operations across the entire cannabis value chain through three business units, with Harvest One serving as the umbrella company over horticultural arm United Greeneries and medical arm Satipharm AG. Each business is strategically located in favourable jurisdictions with supportive regulatory frameworks in place. United Greeneries has received a Canadian medicinal cannabis cultivation licence, making Harvest One one of only a few companies globally with the capacity to commercially cultivate cannabis in a federally regulated environment.

To view the full copy of the Harvest One announcement, please visit:
http://abnnewswire.net/lnk/1QQR15C6


About MMJ PhytoTech Ltd

MMJ PhytoTech Limited (ASX:MMJ) is a global cannabis investment company. MMJ owns a portfolio of minority investments and aims to invest across the full range of emerging cannabis-related sectors including healthcare, technology, infrastructure, logistics, processing, cultivation, equipment and retail. For MMJ's latest investor presentation and news, please visit: http://www.mmjphytotech.com.au/investors/

      

Contact

Andreas Gedeon
Managing Director
Phone: +1-250-713-6302
Email: agedeon@mmj.ca
www.mmjphytotech.com.au



Link: Harvest One Operational Update



Related Companies

MMJ PhytoTech Ltd
  

Harvest One Cannabis Inc


Related Industry Topics:
Food & Beverage Medical Equipment Drugs & OTC Ag Biotechnology Consumers General Health & Pharm General